Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Charles Rudin

1-50 of 184 results

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

scientific article (publication date: 22 October 2015)

Akt stimulates aerobic glycolysis in cancer cells

scientific article (publication date: June 2004)

Efficacy and safety of vismodegib in advanced basal-cell carcinoma.

scientific article

Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer

scientific article published on 2 September 2012

Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung Cancer

scientific article published on November 9, 2011

DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration

scientific article

Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors

scientific article

Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors.

scientific article published on 07 February 2011

Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer

scientific article

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

scientific article published on 14 January 2019

A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro

scientific article

The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies

scientific article published on 09 February 2015

The future of epigenetic therapy in solid tumours--lessons from the past.

scientific article published on 02 April 2013

Cigarette smoking and lung cancer--relative risk estimates for the major histological types from a pooled analysis of case-control studies

scientific article published on 14 December 2011

RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer

scientific article

Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy.

scientific article published on 19 September 2016

Response to MET inhibitors in patients with stage IV lung adenocarcinomas harboring MET mutations causing exon 14 skipping

scientific article

Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists

scientific article

A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo

scientific article

Small cell lung cancer: where do we go from here?

scientific article

Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study

scientific article

Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma

scientific article published on March 2015

Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer

scientific article

Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies.

scientific article published on 23 March 2017

Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity

scientific article

Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial

scientific article

Seneca Valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers

scientific article

Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis.

scientific article published on 2 October 2017

Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer

scientific article published on 19 December 2016

Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis.

scientific article published on February 2017

CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer

scientific article published on 13 June 2016

Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.

scientific article published on 9 March 2016

Phase I study of the Hedgehog pathway inhibitor IPI-926 in adult patients with solid tumors

scientific article published on 10 April 2013

DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2.

scientific article

Small cell lung cancer: will recent progress lead to improved outcomes?

scientific article published in May 2015

An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia.

scientific article published on 3 November 2003

Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?

scientific article published on 29 January 2016

Characteristics of lung cancers harboring NRAS mutations

scientific article (publication date: May 2013)

A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer.

scientific article

Treatment of Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians Guideline

scientific article published on 8 September 2015

Human Alu element retrotransposition induced by genotoxic stress

scientific article published on 26 October 2003

Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come.

scientific article

Bcl-2 and Bcl-xL overexpression inhibits cytochrome c release, activation of multiple caspases, and virus release following coxsackievirus B3 infection.

scientific article published on August 2003

Unravelling the biology of SCLC: implications for therapy

scientific article published on 23 May 2017

Pharmacokinetics of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Locally Advanced or Metastatic Solid Tumors: the Role of Alpha-1-Acid Glycoprotein Binding

scientific article published on February 7, 2011

Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer

scientific article

Phase I Clinical Study of Seneca Valley Virus (SVV-001),a Replication-Competent Picornavirus, in Advanced Solid Tumors with Neuroendocrine Features

scientific article published on February 8, 2011

A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer

scientific article

Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer.

scientific article published on 03 February 2014

Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC.

scientific article published on June 2015